Form4insider filings, from the source

SEC Form 4 · accession 0001607062-16-000655

GENEREX BIOTECHNOLOGY CORP · GNBT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David Brusegard
Officer — Chief Operating Officer
Period of report
Feb 9, 2016
Accepted (ET)
Feb 12, 2016 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001059784

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 9, 2016M5,583,775$0.001A3,916,104D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Common Stock Purchase Option$0.001Feb 9, 2016M546,448DJun 20, 2012Jun 19, 2017Common Stock546,4480D
Common Stock Purchase Option$0.001Feb 9, 2016M1,928,925DApr 1, 2013Apr 1, 2018Common Stock1,928,9250D
Common Stock Purchase Option$0.001Feb 9, 2016M595,239DJun 6, 2013Jun 6, 2018Common Stock595,2390D
Common Stock Purchase Option$0.001Feb 9, 2016M845,492DJan 1, 2014Oct 31, 2018Common Stock845,9420D
Common Stock Purchase Option$0.001Feb 9, 2016M1,667,671AFeb 9, 2016Oct 26, 2020Common Stock1,667,6711,667,671D